Teladoc Health (FRA:4LL) YoY EPS Growth: -10.30% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:4LL Teladoc Health Inc FRA:4LL
57 GF Score
Price €5.52
GF Value €6.81
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Teladoc Health YoY EPS Growth?

Teladoc Health FRA:4LL +3.64% 57 YoY EPS Growth is -10.30% as of Jun. 2026. GuruFocus rates FRA:4LL with a GF Score™ of 57/100 and a GF Value™ of €6.81 (Modestly Undervalued). The stock has 4 warning signs investors should review.

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Teladoc Health's YoY EPS Growth for the quarter that ended in Jun. 2026 was -10.30%.

Teladoc Health's Earnings per Share (Diluted) for the three months ended in Jun. 2026 was €-0.18.

Teladoc Health YoY EPS Growth Historical Data

* Premium members only.

The historical data trend for Teladoc Health's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Teladoc Health YoY EPS Growth Chart

Teladoc Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 45.17 -3,205.55 98.46 -356.14 82.63

Teladoc Health Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 96.39 -39.77 55.06 36.53 -10.30
FRA:4LL
57GF Score
Teladoc Health Inc FRA:4LL
YoY EPS Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Teladoc Health YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Teladoc Health's YoY EPS Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EPS Growth (A: Dec. 2025 )
=(Earnings per Share (Diluted) (A: Dec. 2025 )-Earnings per Share (Diluted) (A: Dec. 2024 ))/ | Earnings per Share (Diluted) (A: Dec. 2024 ) |
=(-0.974--5.606)/ | -5.606 |
=82.63 %

Teladoc Health's YoY EPS Growth for the quarter that ended in Jun. 2026 is calculated as:

YoY EPS Growth (Q: Jun. 2026 )
=(Earnings per Share (Diluted) (Q: Jun. 2026 )-Earnings per Share (Diluted) (Q: Jun. 2025 )) / | Earnings per Share (Diluted) (Q: Jun. 2025 )) |
=(-0.182--0.165)/ | -0.165 |
=-10.30 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EPS Growth →
What does a YoY EPS Growth of -10.30% mean?
Teladoc Health (FRA:4LL) has a YoY EPS Growth of -10.30% as of Jun. 2026. YoY EPS Growth is the percentage change of EPS over the past 12-month. View historical data for Teladoc Health and its competitors.
Is Teladoc Health's YoY EPS Growth too high?
Teladoc Health's current YoY EPS Growth is -10.30%. Overall, Teladoc Health has a GF Score™ of 57/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Teladoc Health's YoY EPS Growth compare to GDRX and CERT?
Teladoc Health's YoY EPS Growth of -10.30% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EPS Growth for a Healthcare Providers & Services company?
A good YoY EPS Growth depends on the Healthcare Providers & Services industry context. However, YoY EPS Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EPS Growth mean?
A high YoY EPS Growth can signal that a stock is expensive relative to its fundamentals. YoY EPS Growth is the percentage change of EPS over the past 12-month. View historical data for Teladoc Health and its competitors. Teladoc Health's current YoY EPS Growth is -10.30%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Teladoc Health stock overvalued right now?
Based on GuruFocus' analysis, Teladoc Health (FRA:4LL) is currently considered Modestly Undervalued. The stock's GF Value™ is €6.81, compared to a current price of €5.52 — trading 19% below its estimated fair value. The current YoY EPS Growth is -10.30%. Teladoc Health's overall GF Score™ is 57/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EPS Growth calculated?
YoY EPS Growth is calculated from a company's financial statements. For Teladoc Health (FRA:4LL), the current YoY EPS Growth is -10.30% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Teladoc Health (FRA:4LL) Overvalued in 2026?

Based on GuruFocus' analysis, Teladoc Health stock appears to be undervalued. The current stock price of €5.52 is trading 19% below its estimated GF Value™ of €6.81. GuruFocus considers Teladoc Health to be Modestly Undervalued.

Key valuation signals for FRA:4LL:

  • YoY EPS Growth: -10.30%
  • GF Value™: €6.81 vs. price of €5.52 (19% below fair value)
  • GF Score™: 57/100 with 4 warning signs

No single metric tells the full story. See the FRA:4LL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Teladoc Health Business Description

Address 155 East 44th Street, Suite 1700, New York, NY, USA, 10017
Teladoc Health Inc is engaged in the provision of virtual healthcare services, connecting patients, providers, and healthcare systems through technology-enabled platforms. The company has two reportable segments: Integrated Care and BetterHelp. The Integrated Care segment provides virtual healthcare solutions, including primary care, mental health, chronic care management, and telehealth enablement services for employers, insurers, and healthcare systems, mainly on a business-to-business basis, while the BetterHelp segment offers direct-to-consumer online mental health services, including counseling and therapy delivered through digital platforms. It generates the majority of its revenue from the Integrated Care segment.
57GF Score

Get the complete analysis for FRA:4LL

YoY EPS Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.52
Price
€6.81
GF Value